Topic: Advances in DNA Damage & Repair and Cancer Drug Resistance
Guest Editors
Dr. Eddy S. Yang
Hazelrig Salter Radiation Oncology Center, 1700 6th Avenue South Birmingham, AL, USA.
Special Issue Introduction
With the recent clinical successes of the PARP inhibitors, the DNA repair pathways have come to the forefront as a bona fide target for personalized treatment of cancers with defective homologous recombination repair. Additionally, DNA repair (genome instability) is a well-established hallmark of cancer and can be a means for dictating tumor sensitivity and resistance to traditional treatments such as chemotherapy and radiation. In this Special Issue, we will provide a basic, translational, and clinical overview of the interactions of the various DNA repair pathways as it relates to carcinogenesis, treatment, and biomarker of response.
Keywords
DNA damage response pathways, DNA repair pathways, cellular response to chemotherapeutics, DNA damage response/repair inhibitors, combination therapy, genome instability, immunotherapy
Submission Deadline
31 Aug 2020
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://www.oaecenter.com/login?JournalId=cdr&IssueId=cdr200831380
Submission Deadline: 31 Aug 2020
Contacts: Susan Song, Assistant Editor, susan@cdrjournal.com
